innoscripta SE
ISIN: DE000A40QVM8
WKN: A40QVM
22 April 2026 12:55PM

EQS-News: innoscripta SE: Annual General Meeting approves dividend of EUR 4.00 per share and confirms Supervisory Board with strong capital markets expertise

innoscripta SE · ISIN: DE000A40QVM8 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2313054

EQS-News: innoscripta SE / Key word(s): AGM/EGM
innoscripta SE: Annual General Meeting approves dividend of EUR 4.00 per share and confirms Supervisory Board with strong capital markets expertise

22.04.2026 / 12:55 CET/CEST
The issuer is solely responsible for the content of this announcement.


innoscripta SE: Annual General Meeting approves dividend of EUR 4.00 per share and confirms Supervisory Board with strong capital markets expertise

Munich, 22 April 2026 – The shareholders of innoscripta SE (“innoscripta”, ISIN: DE000A40QVM8) approved a dividend of EUR 4.00 per share for the 2025 financial year at yesterday’s Annual General Meeting. All agenda items were adopted with a very strong majority of over 97.6%.

As part of the meeting, Philipp von Ilberg, Stefan Berndt-von Bülow and Dr. Erik Massmann were re-elected to the Supervisory Board. The board combines extensive expertise in capital markets, finance and international corporate development:

  • Philipp von Ilberg serves, among other roles, as Chairman of the Supervisory Board of CompuGroup SE & Co. KGaA and brings many years of experience in complex corporate and capital markets transactions.
  • Stefan Berndt-von Bülow has extensive CFO experience in listed technology companies and has successfully led, among other transactions, a NASDAQ IPO.
  • Dr. Erik Massmann most recently served as CFO of the Birkenstock Group and was responsible for its IPO on the NYSE as well as numerous international finance and transformation projects.

With this composition, the Supervisory Board is well positioned to support the company’s capital markets strategy and further international growth.

Shareholders also approved the relocation of the company’s registered seat from Munich to Tutzing. The relocation, which has already been implemented, establishes a clearer organizational structure with key central functions bundled at the new headquarters, while operational units remain in Munich, Cologne and Frankfurt. This strengthens the efficiency of the group structure, provides meaningful economic benefits from a fiscal perspective and creates a solid foundation for further growth, particularly in international markets.

A total of 91.7% of the share capital was represented at the Annual General Meeting. The full voting results are available in the Investors section of the company’s website: https://www.innoscripta.com/en/investoren/hauptversammlung-2026

 

About innoscripta
innoscripta SE offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable.

Contact Details
innoscripta SE
Max Hunger
ir@innoscripta.de

Press Contact
edicto GmbH
Ralf Droz / Svenja Liebig
+49 69 905505-56
innoscripta@edicto.de

 



22.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: innoscripta SE
Arnulfstraße 60
80335 München
Germany
Phone: +4989262004187
E-mail: info@innoscripta.com
Internet: https://www.innoscripta.com
ISIN: DE000A40QVM8
WKN: A40QVM
Listed: Regulated Unofficial Market in Frankfurt (Scale)
EQS News ID: 2313054

 
End of News EQS News Service

2313054  22.04.2026 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2020 2021 2022 2023 2024 2025 2026e
Sales1 8,46 19,83 27,27 39,37 64,71 103,41 145,00
EBITDA1,2 0,63 7,85 9,33 15,62 37,46 63,62 76,00
EBITDA-Margin3 7,47 39,58 34,21 39,68 57,89 61,52 52,41
EBIT1,4 0,48 7,73 9,18 15,47 37,28 63,42 85,00
EBIT-Margin5 5,72 7,73 9,18 39,29 57,61 61,33 58,62
Net Profit (Loss)1 0,29 4,99 6,10 10,27 25,09 42,61 58,00
Net-Margin6 3,48 25,15 22,35 26,09 38,77 41,20 40,00
Cashflow1,7 0,44 1,73 8,89 5,26 20,14 40,83 52,00
Earnings per share8 0,03 0,50 0,61 1,03 2,51 4,26 5,80
Dividend per share8 0,00 0,00 0,50 0,80 2,40 4,00 3,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Nexia

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Innoscripta
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A40QVM DE000A40QVM8 SE 754,00 Mio € 23.05.2025 Kaufen 8FWH4GVX+FJ
* * *
PE 2027e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
12,16 13,00 0,94 45,70 14,02 18,47 7,29
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,80 2,40 4,00 5,31%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
21.04.2026 15.05.2025 21.08.2025 03.11.2025 25.02.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+1,34%
75,40 €
ATH 137,00 €
+3,91% -21,16% -16,50% +0,00% -37,17%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2026          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 by Gereon Kruse #BGFL